7:30pm-9:30pm on Thursday 27 March
Times shown are in GMT (UTC +0) up to the 26th March. For events on or after 27th March times are in BST (UTC +1).
St John's College Old Divinity School, All Saints Passage, CB2 1TP
Join Professors Clare Bryant, Brian Ferguson, Drs Cruz and Jha to discuss how vaccines work and what they will look like in the future. As part of the School of Biological Sciences Harnessing the immune system to fight disease initiative we are bringing experts and the public together to talk about vaccines and get involved with a Q&A session.
Clare Bryant is a veterinary scientist and clinical pharmacologist. She is Professor of Innate Immunity at the University of Cambridge. She is also a Fellow of Queens' College, Cambridge, and of the British Pharmacological Society and a Wellcome Trust Investigator. Clare studies how hosts recognise bacteria using pattern recognition receptors. She is interested in how these PRR are related to chronic inflammatory diseases, for example Alzheimer's disease.
Brian Ferguson is an immunologist. He is Associate Professor of Immunology at the University of Cambridge. He is also principal investigator for the Ferguson Lab, lead for the School of Biological Sciences's Infection and Immunity Theme and a Cambridge BSI representative. Brian studies how our cells sense and respond to virus infection and how this impacts innate and adaptive immunity.
Dr Philip Cruz is Country Medical Director at Moderna UK. With over 16 years of experience in medical affairs in vaccines and paediatrics within the pharmaceutical industry. At Moderna in the UK, he is responsible for the development and execution of the medical affairs strategy for Moderna’s infectious disease franchise and drives scientific leadership for the vaccine portfolio while ensuring compliance with applicable policies and procedures. He also ensures effective interactions with key UK scientific leaders, public health experts, scientific and medical associations, and healthcare authorities at the national level, providing country insight-gathering activities to meet the company's needs around clinical development and innovation in vaccination.
